Department of Neurological Surgery, Northwestern University, Chicago, IL, USA.
Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Neurosurg Rev. 2023 Aug 30;46(1):215. doi: 10.1007/s10143-023-02121-1.
Although typically benign, trigeminal schwannomas (TS) may require surgical resection when large or symptomatic and can cause significant morbidity. This study aims to summarize the literature and synthesize outcomes following surgical resection of TS. A systematic review was performed according to PRISMA guidelines. Data extracted included patient and tumor characteristics, surgical approaches, and postoperative outcomes. Odds ratios (OR) with corresponding 95% confidence intervals (CI) were used for outcome analysis. The initial search yielded 1838 results, of which 26 studies with 974 patients undergoing surgical resection of TS were included. The mean age was 42.9 years and 58.0% were female. The mean tumor diameter was 4.7 cm, with Samii type A, B, C, and D tumors corresponding to 33.4%, 15.8%, 37.2%, and 13.6%, respectively. Over a mean symptom duration of 29 months, patients presented with trigeminal hypesthesia (58.7%), headache (32.8%), trigeminal motor weakness (22.8%), facial pain (21.3%), ataxia (19.4%), diplopia (18.7%), and visual impairment (12.0%). Surgical approaches included supratentorial (61.4%), infratentorial (15.0%), endoscopic (8.6%), combined/staged (5.3%), and anterior (5.7%) or posterior (4.0%) petrosectomy. Postoperative improvement of facial pain (83.9%) was significantly greater than trigeminal motor weakness (33.0%) or hypesthesia (29.4%). The extent of resection (EOR) was reported as gross total (GTR), near total, and subtotal in 77.7%, 7.7%, and 14.6% of cases, respectively. Over a mean follow-up time of 62.6 months, recurrence/progression was noted in 7.4% of patients at a mean time to recurrence of 44.9 months. Patients with GTR had statistically significantly lower odds of recurrence/progression (OR: 0.07; 95% CI: 0.04-0.15) compared to patients with non-GTR. This systematic review and meta-analysis report patient outcomes following surgical resection of TS. EOR was found to be an important predictor of the risk of recurrence. Facial pain was more likely to improve postoperatively than facial hypesthesia. This work reports baseline rates of post-operative complications across studies, establishing benchmarks for neurosurgeons innovating and working to improve surgical outcomes for TS patients.
尽管三叉神经鞘瘤(TS)通常是良性的,但当肿瘤较大或出现症状时,可能需要手术切除,这可能会导致严重的发病率。本研究旨在总结 TS 手术切除后的文献并综合其结果。按照 PRISMA 指南进行了系统评价。提取的数据包括患者和肿瘤特征、手术方法和术后结果。使用优势比(OR)及其相应的 95%置信区间(CI)进行结果分析。最初的搜索产生了 1838 个结果,其中包括 26 项研究,共 974 例 TS 患者接受了手术切除。患者的平均年龄为 42.9 岁,女性占 58.0%。肿瘤平均直径为 4.7cm,Samii 型 A、B、C 和 D 型肿瘤分别占 33.4%、15.8%、37.2%和 13.6%。在平均症状持续时间为 29 个月时,患者出现三叉神经感觉减退(58.7%)、头痛(32.8%)、三叉神经运动无力(22.8%)、面部疼痛(21.3%)、共济失调(19.4%)、复视(18.7%)和视力障碍(12.0%)。手术方法包括:颅上(61.4%)、颅下(15.0%)、内镜(8.6%)、联合/分期(5.3%)、前(5.7%)或后(4.0%)岩骨切除术。术后面部疼痛改善(83.9%)明显优于三叉神经运动无力(33.0%)或感觉减退(29.4%)。肿瘤全切除(GTR)、近全切除和次全切除的切除范围(EOR)分别占 77.7%、7.7%和 14.6%。在平均 62.6 个月的随访中,7.4%的患者在平均复发时间 44.9 个月后出现复发/进展。与非 GTR 患者相比,GTR 患者的复发/进展风险明显降低(OR:0.07;95%CI:0.04-0.15)。本系统评价和荟萃分析报告了 TS 手术切除后的患者结果。EOR 被发现是复发风险的一个重要预测因素。术后面部疼痛改善的可能性大于面部感觉减退。本研究报告了各研究中术后并发症的基线发生率,为神经外科医生创新和努力改善 TS 患者的手术结果提供了基准。